OctoPlus N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
26 sep 2010 - 22:37
Statutaire naam
OctoPlus N.V.
Titel
OctoPlus wins drug development contract from global pharmaceutical company
Bericht
OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), announces today that it has signed a pharmaceutical development contract with an undisclosed global pharmaceutical company. The undisclosed contract value will make a material contribution to OctoPlus’ annual revenues.
Under the contract terms, OctoPlus will perform formulation development for the client’s product candidate.
Datum laatste update: 01 september 2024